These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33076866)

  • 1. Genotype-Informed Versus Empiric Management Of VirEmia (GIVE MOVE): study protocol of an open-label randomised clinical trial in children and adolescents living with HIV in Lesotho and Tanzania.
    Brown JA; Ringera I; Luoga E; Cheleboi M; Kimera N; Muhairwe J; Kayembe BP; Molapo Hlasoa M; Kabundi L; Yav CWD; Mothobi B; Thahane L; Amstutz A; Bachmann N; Mollel GJ; Bresser M; Glass TR; Paris DH; Klimkait T; Weisser M; Labhardt ND
    BMC Infect Dis; 2020 Oct; 20(1):773. PubMed ID: 33076866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance-informed versus empirical management of viraemia in children and adolescents with HIV in Lesotho and Tanzania (GIVE MOVE trial): a multisite, open-label randomised controlled trial.
    Brown JA; Ringera IK; Luoga E; Bresser M; Mothobi B; Kabundi L; Ilunga M; Mokhele K; Isaac AB; Tsoaeli N; Mbaya T; Simba B; Mayogu K; Mabula E; Cheleboi M; Molatelle M; Kimera N; Mollel GJ; Sando D; Tschumi N; Amstutz A; Thahane L; Hlasoa MM; Kayembe BP; Muhairwe J; Klimkait T; Glass TR; Weisser M; Labhardt ND
    Lancet Glob Health; 2024 Aug; 12(8):e1312-e1322. PubMed ID: 39030062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SESOTHO trial ("Switch Either near Suppression Or THOusand") - switch to second-line versus WHO-guided standard of care for unsuppressed patients on first-line ART with viremia below 1000 copies/mL: protocol of a multicenter, parallel-group, open-label, randomized clinical trial in Lesotho, Southern Africa.
    Amstutz A; Nsakala BL; Vanobberghen F; Muhairwe J; Glass TR; Achieng B; Sepeka M; Tlali K; Sao L; Thin K; Klimkait T; Battegay M; Labhardt ND
    BMC Infect Dis; 2018 Feb; 18(1):76. PubMed ID: 29433430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switch to second-line versus continued first-line antiretroviral therapy for patients with low-level HIV-1 viremia: An open-label randomized controlled trial in Lesotho.
    Amstutz A; Nsakala BL; Vanobberghen F; Muhairwe J; Glass TR; Namane T; Mpholo T; Battegay M; Klimkait T; Labhardt ND
    PLoS Med; 2020 Sep; 17(9):e1003325. PubMed ID: 32936795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When patients fail UNAIDS' last 90 - the "failure cascade" beyond 90-90-90 in rural Lesotho, Southern Africa: a
    Labhardt ND; Ringera I; Lejone TI; Cheleboi M; Wagner S; Muhairwe J; Klimkait T
    J Int AIDS Soc; 2017 Jul; 20(1):21803. PubMed ID: 28777506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VIBRA trial - Effect of village-based refill of ART following home-based same-day ART initiation vs clinic-based ART refill on viral suppression among individuals living with HIV: protocol of a cluster-randomized clinical trial in rural Lesotho.
    Amstutz A; Lejone TI; Khesa L; Muhairwe J; Nsakala BL; Tlali K; Bresser M; Tediosi F; Kopo M; Kao M; Klimkait T; Battegay M; Glass TR; Labhardt ND
    Trials; 2019 Aug; 20(1):522. PubMed ID: 31439004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of routine viral load monitoring: higher levels of resistance at ART failure in Uganda and Lesotho compared with Switzerland.
    Bachmann N; von Braun A; Labhardt ND; Kadelka C; Günthard HF; Sekaggya-Wiltshire C; Castelnuovo B; Kambugu A; Lejone TI; Böni J; Yerly S; Perreau M; Klimkait T; Kouyos RD; Fehr J;
    J Antimicrob Chemother; 2019 Feb; 74(2):468-472. PubMed ID: 30476115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Suboptimal Pediatric HIV Viral Load Cascade: Multidistrict Cohort Study Among Children Taking Antiretroviral Therapy in Lesotho, Southern Africa.
    Muhairwe JA; Brown JA; Motaboli L; Nsakala BL; Lerotholi M; Amstutz A; Klimkait T; Glass TR; Labhardt ND
    Pediatr Infect Dis J; 2022 Mar; 41(3):e75-e80. PubMed ID: 34862344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial.
    Szubert AJ; Prendergast AJ; Spyer MJ; Musiime V; Musoke P; Bwakura-Dangarembizi M; Nahirya-Ntege P; Thomason MJ; Ndashimye E; Nkanya I; Senfuma O; Mudenge B; Klein N; Gibb DM; Walker AS;
    PLoS Med; 2017 Nov; 14(11):e1002432. PubMed ID: 29136032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Treatment Cascade in Children With Unsuppressed Viral Load-A Reality Check in Rural Lesotho, Southern Africa.
    Lejone TI; Ringera I; Cheleboi M; Wagner S; Muhairwe J; Klimkait T; Labhardt ND
    J Acquir Immune Defic Syndr; 2018 Mar; 77(3):250-256. PubMed ID: 29189416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virological Outcome After Choice of Antiretroviral Regimen Guided by Proviral HIV-1 DNA Genotyping in a Real-Life Cohort of HIV-Infected Patients.
    Meybeck A; Alidjinou EK; Huleux T; Boucher A; Tetart M; Choisy P; Bocket L; Ajana F; Robineau O
    AIDS Patient Care STDS; 2020 Feb; 34(2):51-58. PubMed ID: 32049556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensive drug resistance during low-level HIV viraemia while taking NNRTI-based ART supports lowering the viral load threshold for regimen switch in resource-limited settings: a pre-planned analysis from the SESOTHO trial.
    Brown JA; Amstutz A; Nsakala BL; Seeburg U; Vanobberghen F; Muhairwe J; Klimkait T; Labhardt ND
    J Antimicrob Chemother; 2021 Apr; 76(5):1294-1298. PubMed ID: 33599270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial.
    Dahourou DL; Amorissani-Folquet M; Malateste K; Amani-Bosse C; Coulibaly M; Seguin-Devaux C; Toni T; Ouédraogo R; Blanche S; Yonaba C; Eboua F; Lepage P; Avit D; Ouédraogo S; Van de Perre P; N'Gbeche S; Kalmogho A; Salamon R; Meda N; Timité-Konan M; Leroy V;
    BMC Med; 2017 Apr; 15(1):85. PubMed ID: 28434406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of treatment response, drug resistance and HIV-1 variability among adolescents on first- and second-line antiretroviral therapy: a study protocol for a prospective observational study in the centre region of Cameroon (EDCTP READY-study).
    Fokam J; Santoro MM; Takou D; Njom-Nlend AE; Ndombo PK; Kamgaing N; Kamta C; Essiane A; Sosso SM; Ndjolo A; Colizzi V; Perno CF
    BMC Pediatr; 2019 Jul; 19(1):226. PubMed ID: 31277610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BREATHER (PENTA 16) short-cycle therapy (SCT) (5 days on/2 days off) in young people with chronic human immunodeficiency virus infection: an open, randomised, parallel-group Phase II/III trial.
    Butler K; Inshaw J; Ford D; Bernays S; Scott K; Kenny J; Klein N; Turkova A; Harper L; Nastouli E; Paparini S; Choudhury R; Rhodes T; Babiker A; Gibb D
    Health Technol Assess; 2016 Jun; 20(49):1-108. PubMed ID: 27377073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should viral load thresholds be lowered?: Revisiting the WHO definition for virologic failure in patients on antiretroviral therapy in resource-limited settings.
    Labhardt ND; Bader J; Lejone TI; Ringera I; Hobbins MA; Fritz C; Ehmer J; Cerutti B; Puga D; Klimkait T
    Medicine (Baltimore); 2016 Jul; 95(28):e3985. PubMed ID: 27428189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEBRA trial - effect of a peer-educator coordinated preference-based ART service delivery model on viral suppression among adolescents and young adults living with HIV: protocol of a cluster-randomized clinical trial in rural Lesotho.
    Lejone TI; Kopo M; Bachmann N; Brown JA; Glass TR; Muhairwe J; Matsela T; Scherrer R; Chere L; Namane T; Labhardt ND; Amstutz A
    BMC Public Health; 2020 Mar; 20(1):425. PubMed ID: 32228531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High rates of virological failure and drug resistance in perinatally HIV-1-infected children and adolescents receiving lifelong antiretroviral therapy in routine clinics in Togo.
    Salou M; Dagnra AY; Butel C; Vidal N; Serrano L; Takassi E; Konou AA; Houndenou S; Dapam N; Singo-Tokofaï A; Pitche P; Atakouma Y; Prince-David M; Delaporte E; Peeters M
    J Int AIDS Soc; 2016; 19(1):20683. PubMed ID: 27125320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of intensive adherence counselling in achieving an undetectable viral load among people on antiretroviral therapy with low-level viraemia in Uganda.
    Nanyeenya N; Nakanjako D; Makumbi F; Nakigozi G; Nalugoda F; Kigozi G; Nasuuna E; Kibira SPS; Nabadda S; Kiyaga C; Huzaifah M; Kiwanuka N
    HIV Med; 2024 Feb; 25(2):245-253. PubMed ID: 37853605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.